Arcutis Biotherapeutics, Inc. Sustainability Profile
Arcutis Biotherapeutics, Inc., a leading biopharmaceutical company based in the United States, focuses on developing innovative treatments for dermatological conditions. Founded in 2017, Arcutis has quickly established itself in the industry with a commitment to addressing unmet medical needs in skin health. The company’s core products include topical therapies designed to treat conditions such as psoriasis and atopic dermatitis, distinguished by their unique formulation and efficacy. Arcutis has achieved significant milestones, including successful clinical trials that have positioned it as a key player in the dermatology market. With a strong emphasis on research and development, Arcutis continues to advance its portfolio, aiming to improve the quality of life for patients suffering from skin disorders.
DitchCarbon Score
How does Arcutis Biotherapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Arcutis Biotherapeutics, Inc.'s score of 25 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Arcutis Biotherapeutics, Inc.'s reported carbon emissions
Arcutis Biotherapeutics, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Arcutis may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the biotherapeutics industry increasingly prioritises sustainability, it will be important for Arcutis to consider developing and communicating its climate strategies in the future.
How Carbon Intensive is Arcutis Biotherapeutics, Inc.'s Industry?
How Carbon Intensive is Arcutis Biotherapeutics, Inc.'s Location?
Arcutis Biotherapeutics, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Arcutis Biotherapeutics, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
